Skip to content
Clinical Trials – home
Verifiedinfo

IRCCS Ospedale Policlinico San Martino

Italy Largo Rosanna Benzi 10, 16132 Genoa, Italy

  • 195 trials recruiting
  • Non-small cell lung cancer · Asthma · Breast cancer
  • Adults and children

About Specializations

IRCCS Ospedale Policlinico San Martino in Genoa, Italy specialises in clinical trials of conditions such as Non-small cell lung cancer, Asthma, Breast cancer, Hormone receptor positive HER2 negative breast cancer, and other specialisations. This site conducts important research.

Main research areas of the site

Neoplasms and Oncology Research

At IRCCS Ospedale Policlinico San Martino in Genoa, clinical trials in the Department of Internal Medicine and Medicine Specialities focus on neoplasms, with a strong emphasis on non-small cell lung cancer. This research is aimed at evaluating new treatment options and comparing their ability to improve patient outcomes in a difficult-to-treat cancer setting.

  • Studies in non-small cell lung cancer
  • Evaluation of new therapies versus established treatment options
  • Assessment of survival and disease control in patients with advanced cancer

The trials at this site are designed to better understand how emerging cancer treatments may affect overall disease management, with attention to effectiveness in previously treated patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Largo Rosanna Benzi 1016132 GenoaItaly
Recruiting now
195 trials
Conditions studied
195
Partner status
Verified

More sites in GenoaItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

478 clinical trials

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Alks 2680
  • Sponsor:Alkermes Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Alks 2680
  • Sponsor:Alkermes Inc.
Countries:ItalyItaly
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:USNOFLAST
  • Sponsor:Zydus Therapeutics Inc.
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:MOLNUPIRAVIR
  • Sponsor:Merck Sharp & Dohme LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Summit Therapeutics Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).